These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [A case of ticlopidine induced acute cholestatic hepatitis and pure red cell aplasia]. Author: Lee JY, Park EB, Ahn JH, Suh SJ, Jung YK, Kim JH, Shin BK, Yang JH, Yeon JE, Byun KS. Journal: Korean J Hepatol; 2008 Mar; 14(1):102-7. PubMed ID: 18367863. Abstract: Ticlopidine inhibits platelet aggregation and provides beneficial secondary prevention of cerebrovascular and coronary artery disease. Frequently reported adverse effects of ticlopidine include diarrhea, nausea, and rash. However, to our knowledge, there are only a few published reports of the simultaneous occurrence of cholestatic hepatitis and pure red cell aplasia. Here we report a patient with simultaneous severe cholestatic hepatitis and pure red cell aplasia associated with ticlopidine. Although these adverse effects are rare, periodic hematological and liver function tests are recommended after starting ticlopidine.[Abstract] [Full Text] [Related] [New Search]